Mikhail Blagosklonny is someone who has impacted the field of cancer research immensely. He is extremely dedicated to the field and has been working in oncological research since the beginning of his career. He has been instrumental in bringing several new treatments for various kinds of cancers to doctors all over the world so that they can provide the best course of treatment to their patients.One of the first endeavors that Mikhail Blagosklonny had in the field of oncological research was when he started working for a company known as Ordway. The company was mainly involved in researching new treatments for the treatment of cancer, which was exactly the field that Mikhail Blagosklonny wanted to work in. He saw this as a brilliant fit and an excellent opportunity to do what he actually wanted to. He spent his time at the company researching and even made considerable discoveries which have impacted the medical field. He worked at the company for several years before branching out into his endeavors.
Mikhail Blagosklonny would mainly work towards finding new treatment methodologies for patients with cancer. While he was researching some of the drugs that were being used, he came across a compound called Rapamycin, which shows evidence that it would help improve the life expectancy of patients. It is a compound that is extremely common in cancer treating medicines. This discovery was seen as groundbreaking in the medical field since there isn’t all that much research being done on drugs that can potentially improve the life expectancy of those who take them. Since then, this has been one of the main arrays that Mikhail Blagosklonny has been researching in, even though it has made him stray away from his initial goal of helping find more viable methods for the treatment of cancer.
Teaching has also been something that has inspired Mikhail Blagosklonny since he believes that this is one of the best ways to give back to society. Soon after passing out of medical school, Mikhail Blagosklonny started working at the New York School of Medicine. He taught numerous batches of students here, who all looked up to him as a mentor. Today, Mikhail Blagosklonny is the head of oncological department at the Roswell Park Cancer Institute. He uses his incredible experience in the field to impart knowledge to his students. He hopes that he can inspire the new batches of students so that they will take up oncological research to help combat a disease that affects so many people every year. Mikhail Blagosklonny is also the editor in chief of his publication known as Oncotarget. With the amount of time he has spent in the field, he knows how hard it is to come across groundbreaking discoveries from doctors all over the world. He, therefore, decided to start Oncotarget which is a weekly publication that is open to doctors from all over the world. They are all encouraged to send in their work and writeups so that others can also know about them in an easier manner.